NeoRx tests radiotherapy technology in metastatic breast cancer
This article was originally published in Clinica
Executive Summary
NeoRx is seeking permission from the US FDA to start a phase II clinical study of its Skeletal Targeted Radiotherapy (STR) treatment in patients with breast cancer that has metastasised to the bone.